nodes	percent_of_prediction	percent_of_DWPC	metapath
Pipotiazine—DRD1—attention deficit hyperactivity disorder	0.371	0.445	CbGaD
Pipotiazine—DRD2—attention deficit hyperactivity disorder	0.262	0.313	CbGaD
Pipotiazine—HTR2A—attention deficit hyperactivity disorder	0.202	0.242	CbGaD
Pipotiazine—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.0053	0.17	CbGeAlD
Pipotiazine—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00281	0.0902	CbGeAlD
Pipotiazine—DRD1—forebrain—attention deficit hyperactivity disorder	0.00168	0.0539	CbGeAlD
Pipotiazine—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.00133	0.0427	CbGeAlD
Pipotiazine—DRD1—midbrain—attention deficit hyperactivity disorder	0.00111	0.0356	CbGeAlD
Pipotiazine—HTR1A—forebrain—attention deficit hyperactivity disorder	0.0011	0.0353	CbGeAlD
Pipotiazine—DRD2—forebrain—attention deficit hyperactivity disorder	0.000995	0.0319	CbGeAlD
Pipotiazine—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000931	0.0298	CbGeAlD
Pipotiazine—DRD1—nervous system—attention deficit hyperactivity disorder	0.000914	0.0293	CbGeAlD
Pipotiazine—DRD1—central nervous system—attention deficit hyperactivity disorder	0.00088	0.0282	CbGeAlD
Pipotiazine—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000727	0.0233	CbGeAlD
Pipotiazine—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.000723	0.0232	CbGeAlD
Pipotiazine—DRD1—brain—attention deficit hyperactivity disorder	0.000698	0.0224	CbGeAlD
Pipotiazine—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.000696	0.0223	CbGeAlD
Pipotiazine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000657	0.021	CbGeAlD
Pipotiazine—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000656	0.021	CbGeAlD
Pipotiazine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000598	0.0192	CbGeAlD
Pipotiazine—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000598	0.0191	CbGeAlD
Pipotiazine—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000575	0.0184	CbGeAlD
Pipotiazine—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000562	0.018	CbGeAlD
Pipotiazine—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000555	0.0178	CbGeAlD
Pipotiazine—SLC22A1—brain—attention deficit hyperactivity disorder	0.000553	0.0177	CbGeAlD
Pipotiazine—DRD2—nervous system—attention deficit hyperactivity disorder	0.00054	0.0173	CbGeAlD
Pipotiazine—ALB—brain—attention deficit hyperactivity disorder	0.000529	0.017	CbGeAlD
Pipotiazine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.00052	0.0167	CbGeAlD
Pipotiazine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000508	0.0163	CbGeAlD
Pipotiazine—HTR1A—brain—attention deficit hyperactivity disorder	0.000457	0.0146	CbGeAlD
Pipotiazine—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000433	0.0139	CbGeAlD
Pipotiazine—DRD2—brain—attention deficit hyperactivity disorder	0.000413	0.0132	CbGeAlD
Pipotiazine—Zuclopenthixol—DRD5—attention deficit hyperactivity disorder	0.000385	0.0401	CrCbGaD
Pipotiazine—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000356	0.0114	CbGeAlD
Pipotiazine—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000343	0.011	CbGeAlD
Pipotiazine—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000335	0.0107	CbGeAlD
Pipotiazine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00033	0.0106	CbGeAlD
Pipotiazine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000324	0.0104	CbGeAlD
Pipotiazine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000317	0.0102	CbGeAlD
Pipotiazine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000312	0.01	CbGeAlD
Pipotiazine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000305	0.00978	CbGeAlD
Pipotiazine—HTR2A—brain—attention deficit hyperactivity disorder	0.000272	0.00872	CbGeAlD
Pipotiazine—Acetophenazine—DRD1—attention deficit hyperactivity disorder	0.000264	0.0275	CrCbGaD
Pipotiazine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000248	0.00795	CbGeAlD
Pipotiazine—Methotrimeprazine—DRD5—attention deficit hyperactivity disorder	0.000236	0.0246	CrCbGaD
Pipotiazine—Propericiazine—DRD1—attention deficit hyperactivity disorder	0.000233	0.0243	CrCbGaD
Pipotiazine—Methotrimeprazine—ADRA2C—attention deficit hyperactivity disorder	0.000223	0.0232	CrCbGaD
Pipotiazine—Quetiapine—DRD5—attention deficit hyperactivity disorder	0.000223	0.0232	CrCbGaD
Pipotiazine—Propericiazine—ADRA2A—attention deficit hyperactivity disorder	0.000216	0.0225	CrCbGaD
Pipotiazine—Quetiapine—ADRA2C—attention deficit hyperactivity disorder	0.00021	0.0219	CrCbGaD
Pipotiazine—Domperidone—DRD3—attention deficit hyperactivity disorder	0.000203	0.0212	CrCbGaD
Pipotiazine—Acetophenazine—DRD2—attention deficit hyperactivity disorder	0.000186	0.0194	CrCbGaD
Pipotiazine—Chlorpromazine—DRD5—attention deficit hyperactivity disorder	0.00018	0.0188	CrCbGaD
Pipotiazine—Zuclopenthixol—DRD1—attention deficit hyperactivity disorder	0.000167	0.0174	CrCbGaD
Pipotiazine—Triflupromazine—DRD1—attention deficit hyperactivity disorder	0.000162	0.0168	CrCbGaD
Pipotiazine—Zuclopenthixol—ADRA2A—attention deficit hyperactivity disorder	0.000155	0.0162	CrCbGaD
Pipotiazine—Acepromazine—DRD1—attention deficit hyperactivity disorder	0.00015	0.0156	CrCbGaD
Pipotiazine—Thioproperazine—DRD1—attention deficit hyperactivity disorder	0.000146	0.0152	CrCbGaD
Pipotiazine—Mesoridazine—DRD3—attention deficit hyperactivity disorder	0.000145	0.0151	CrCbGaD
Pipotiazine—Thiothixene—DRD1—attention deficit hyperactivity disorder	0.000144	0.015	CrCbGaD
Pipotiazine—Propiomazine—DRD4—attention deficit hyperactivity disorder	0.000141	0.0147	CrCbGaD
Pipotiazine—Domperidone—DRD2—attention deficit hyperactivity disorder	0.000141	0.0147	CrCbGaD
Pipotiazine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.00014	0.0146	CrCbGaD
Pipotiazine—Thiothixene—ADRA2A—attention deficit hyperactivity disorder	0.000134	0.0139	CrCbGaD
Pipotiazine—Cyamemazine—HTR2A—attention deficit hyperactivity disorder	0.000127	0.0132	CrCbGaD
Pipotiazine—Fluphenazine—DRD3—attention deficit hyperactivity disorder	0.000127	0.0132	CrCbGaD
Pipotiazine—Fluphenazine—DRD1—attention deficit hyperactivity disorder	0.000124	0.0129	CrCbGaD
Pipotiazine—Methotrimeprazine—DRD4—attention deficit hyperactivity disorder	0.000121	0.0126	CrCbGaD
Pipotiazine—Propiomazine—DRD1—attention deficit hyperactivity disorder	0.00012	0.0125	CrCbGaD
Pipotiazine—Zuclopenthixol—DRD2—attention deficit hyperactivity disorder	0.000118	0.0123	CrCbGaD
Pipotiazine—Fluphenazine—ADRA2A—attention deficit hyperactivity disorder	0.000116	0.012	CrCbGaD
Pipotiazine—Triflupromazine—DRD2—attention deficit hyperactivity disorder	0.000114	0.0119	CrCbGaD
Pipotiazine—Quetiapine—DRD4—attention deficit hyperactivity disorder	0.000114	0.0119	CrCbGaD
Pipotiazine—Thioridazine—DRD1—attention deficit hyperactivity disorder	0.000107	0.0112	CrCbGaD
Pipotiazine—Clomipramine—ADRA2A—attention deficit hyperactivity disorder	0.000106	0.011	CrCbGaD
Pipotiazine—Acepromazine—DRD2—attention deficit hyperactivity disorder	0.000105	0.011	CrCbGaD
Pipotiazine—Promazine—DRD4—attention deficit hyperactivity disorder	0.000105	0.0109	CrCbGaD
Pipotiazine—Methotrimeprazine—DRD3—attention deficit hyperactivity disorder	0.000104	0.0109	CrCbGaD
Pipotiazine—Thioproperazine—DRD2—attention deficit hyperactivity disorder	0.000103	0.0107	CrCbGaD
Pipotiazine—Methotrimeprazine—DRD1—attention deficit hyperactivity disorder	0.000102	0.0107	CrCbGaD
Pipotiazine—Thiothixene—DRD2—attention deficit hyperactivity disorder	0.000101	0.0106	CrCbGaD
Pipotiazine—Quetiapine—HTR1B—attention deficit hyperactivity disorder	0.000101	0.0105	CrCbGaD
Pipotiazine—Mesoridazine—DRD2—attention deficit hyperactivity disorder	0.0001	0.0104	CrCbGaD
Pipotiazine—Thioridazine—ADRA2A—attention deficit hyperactivity disorder	9.95e-05	0.0104	CrCbGaD
Pipotiazine—Perphenazine—DRD1—attention deficit hyperactivity disorder	9.83e-05	0.0102	CrCbGaD
Pipotiazine—Quetiapine—DRD3—attention deficit hyperactivity disorder	9.82e-05	0.0102	CrCbGaD
Pipotiazine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	9.69e-05	0.0101	CrCbGaD
Pipotiazine—Quetiapine—DRD1—attention deficit hyperactivity disorder	9.64e-05	0.01	CrCbGaD
Pipotiazine—Methotrimeprazine—ADRA2A—attention deficit hyperactivity disorder	9.5e-05	0.0099	CrCbGaD
Pipotiazine—Chlorpromazine—DRD4—attention deficit hyperactivity disorder	9.21e-05	0.0096	CrCbGaD
Pipotiazine—Perphenazine—ADRA2A—attention deficit hyperactivity disorder	9.13e-05	0.00952	CrCbGaD
Pipotiazine—Zuclopenthixol—HTR2A—attention deficit hyperactivity disorder	9.09e-05	0.00947	CrCbGaD
Pipotiazine—Quetiapine—ADRA2A—attention deficit hyperactivity disorder	8.96e-05	0.00933	CrCbGaD
Pipotiazine—Promazine—DRD1—attention deficit hyperactivity disorder	8.86e-05	0.00923	CrCbGaD
Pipotiazine—Fluphenazine—DRD2—attention deficit hyperactivity disorder	8.76e-05	0.00913	CrCbGaD
Pipotiazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	8.71e-05	0.000702	CbGpPWpGaD
Pipotiazine—DRD1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	8.71e-05	0.000701	CbGpPWpGaD
Pipotiazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	8.64e-05	0.000695	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	8.62e-05	0.000694	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	8.61e-05	0.000693	CbGpPWpGaD
Pipotiazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	8.6e-05	0.000693	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	8.57e-05	0.00069	CbGpPWpGaD
Pipotiazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	8.5e-05	0.000684	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	8.47e-05	0.000682	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	8.44e-05	0.00068	CbGpPWpGaD
Pipotiazine—Propiomazine—DRD2—attention deficit hyperactivity disorder	8.43e-05	0.00878	CrCbGaD
Pipotiazine—Promazine—ADRA2A—attention deficit hyperactivity disorder	8.23e-05	0.00858	CrCbGaD
Pipotiazine—ALB—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	8.16e-05	0.000657	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	8.16e-05	0.000657	CbGpPWpGaD
Pipotiazine—Acepromazine—HTR2A—attention deficit hyperactivity disorder	8.15e-05	0.00849	CrCbGaD
Pipotiazine—DRD1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	8.12e-05	0.000653	CbGpPWpGaD
Pipotiazine—SLC22A1—Neuronal System—COMT—attention deficit hyperactivity disorder	8.06e-05	0.000649	CbGpPWpGaD
Pipotiazine—Clomipramine—SLC6A4—attention deficit hyperactivity disorder	8.06e-05	0.0084	CrCbGaD
Pipotiazine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	8.01e-05	0.000645	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	8.01e-05	0.000645	CbGpPWpGaD
Pipotiazine—SLC22A1—Neuronal System—MAOA—attention deficit hyperactivity disorder	8e-05	0.000645	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	7.99e-05	0.000644	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	7.97e-05	0.000642	CbGpPWpGaD
Pipotiazine—Thioproperazine—HTR2A—attention deficit hyperactivity disorder	7.96e-05	0.0083	CrCbGaD
Pipotiazine—Chlorpromazine—DRD3—attention deficit hyperactivity disorder	7.94e-05	0.00828	CrCbGaD
Pipotiazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	7.92e-05	0.000638	CbGpPWpGaD
Pipotiazine—Thiothixene—HTR2A—attention deficit hyperactivity disorder	7.83e-05	0.00816	CrCbGaD
Pipotiazine—Chlorpromazine—DRD1—attention deficit hyperactivity disorder	7.8e-05	0.00812	CrCbGaD
Pipotiazine—Mesoridazine—HTR2A—attention deficit hyperactivity disorder	7.73e-05	0.00806	CrCbGaD
Pipotiazine—HTR1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	7.72e-05	0.000621	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	7.59e-05	0.000611	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	7.58e-05	0.000611	CbGpPWpGaD
Pipotiazine—Thioridazine—DRD2—attention deficit hyperactivity disorder	7.55e-05	0.00787	CrCbGaD
Pipotiazine—DRD2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	7.52e-05	0.000606	CbGpPWpGaD
Pipotiazine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	7.49e-05	0.000603	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	7.49e-05	0.000603	CbGpPWpGaD
Pipotiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	7.46e-05	0.000601	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	7.41e-05	0.000597	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	7.4e-05	0.000596	CbGpPWpGaD
Pipotiazine—Imipramine—SLC6A3—attention deficit hyperactivity disorder	7.35e-05	0.00766	CrCbGaD
Pipotiazine—HTR1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	7.26e-05	0.000585	CbGpPWpGaD
Pipotiazine—Chlorpromazine—ADRA2A—attention deficit hyperactivity disorder	7.25e-05	0.00755	CrCbGaD
Pipotiazine—Methotrimeprazine—DRD2—attention deficit hyperactivity disorder	7.21e-05	0.00751	CrCbGaD
Pipotiazine—DRD2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	7.16e-05	0.000577	CbGpPWpGaD
Pipotiazine—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	7.13e-05	0.000574	CbGpPWpGaD
Pipotiazine—Promethazine—DRD2—attention deficit hyperactivity disorder	7.1e-05	0.0074	CrCbGaD
Pipotiazine—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	7.08e-05	0.00057	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	7.05e-05	0.000568	CbGpPWpGaD
Pipotiazine—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	7.03e-05	0.000566	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	7.02e-05	0.000565	CbGpPWpGaD
Pipotiazine—Trifluoperazine—DRD2—attention deficit hyperactivity disorder	7.01e-05	0.0073	CrCbGaD
Pipotiazine—DRD2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	7e-05	0.000563	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	6.98e-05	0.000562	CbGpPWpGaD
Pipotiazine—Perphenazine—DRD2—attention deficit hyperactivity disorder	6.93e-05	0.00722	CrCbGaD
Pipotiazine—HTR2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.91e-05	0.000556	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.88e-05	0.000554	CbGpPWpGaD
Pipotiazine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	6.84e-05	0.000551	CbGpPWpGaD
Pipotiazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	6.84e-05	0.000551	CbGpPWpGaD
Pipotiazine—Quetiapine—DRD2—attention deficit hyperactivity disorder	6.79e-05	0.00708	CrCbGaD
Pipotiazine—DRD2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.78e-05	0.000546	CbGpPWpGaD
Pipotiazine—Fluphenazine—HTR2A—attention deficit hyperactivity disorder	6.77e-05	0.00705	CrCbGaD
Pipotiazine—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	6.71e-05	0.00054	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.67e-05	0.000537	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.66e-05	0.000536	CbGpPWpGaD
Pipotiazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	6.58e-05	0.00053	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.58e-05	0.00053	CbGpPWpGaD
Pipotiazine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	6.56e-05	0.000528	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.55e-05	0.000528	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.53e-05	0.000526	CbGpPWpGaD
Pipotiazine—Propiomazine—HTR2A—attention deficit hyperactivity disorder	6.51e-05	0.00679	CrCbGaD
Pipotiazine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	6.51e-05	0.000524	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.51e-05	0.000524	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.47e-05	0.000521	CbGpPWpGaD
Pipotiazine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	6.47e-05	0.000521	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	6.44e-05	0.000519	CbGpPWpGaD
Pipotiazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.42e-05	0.000517	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.4e-05	0.000515	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.37e-05	0.000513	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.27e-05	0.000505	CbGpPWpGaD
Pipotiazine—Promazine—DRD2—attention deficit hyperactivity disorder	6.25e-05	0.00651	CrCbGaD
Pipotiazine—Clomipramine—HTR2A—attention deficit hyperactivity disorder	6.19e-05	0.00645	CrCbGaD
Pipotiazine—HTR2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	6.03e-05	0.000485	CbGpPWpGaD
Pipotiazine—HTR1A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	5.94e-05	0.000478	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.92e-05	0.000477	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.85e-05	0.000471	CbGpPWpGaD
Pipotiazine—Thioridazine—HTR2A—attention deficit hyperactivity disorder	5.83e-05	0.00608	CrCbGaD
Pipotiazine—DRD2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.73e-05	0.000461	CbGpPWpGaD
Pipotiazine—DRD1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.68e-05	0.000458	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.64e-05	0.000454	CbGpPWpGaD
Pipotiazine—DRD1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	5.64e-05	0.000454	CbGpPWpGaD
Pipotiazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.64e-05	0.000454	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.63e-05	0.000454	CbGpPWpGaD
Pipotiazine—Methotrimeprazine—HTR2A—attention deficit hyperactivity disorder	5.57e-05	0.0058	CrCbGaD
Pipotiazine—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	5.55e-05	0.000447	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.54e-05	0.000446	CbGpPWpGaD
Pipotiazine—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.51e-05	0.000444	CbGpPWpGaD
Pipotiazine—Imipramine—SLC6A4—attention deficit hyperactivity disorder	5.5e-05	0.00573	CrCbGaD
Pipotiazine—Chlorpromazine—DRD2—attention deficit hyperactivity disorder	5.5e-05	0.00573	CrCbGaD
Pipotiazine—Promethazine—HTR2A—attention deficit hyperactivity disorder	5.49e-05	0.00572	CrCbGaD
Pipotiazine—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.48e-05	0.000441	CbGpPWpGaD
Pipotiazine—Imipramine—DRD2—attention deficit hyperactivity disorder	5.47e-05	0.0057	CrCbGaD
Pipotiazine—Trifluoperazine—HTR2A—attention deficit hyperactivity disorder	5.41e-05	0.00564	CrCbGaD
Pipotiazine—Perphenazine—HTR2A—attention deficit hyperactivity disorder	5.35e-05	0.00558	CrCbGaD
Pipotiazine—Quetiapine—HTR2A—attention deficit hyperactivity disorder	5.25e-05	0.00547	CrCbGaD
Pipotiazine—HTR2A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	5.13e-05	0.000413	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	5.11e-05	0.000412	CbGpPWpGaD
Pipotiazine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.1e-05	0.00041	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.09e-05	0.00041	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	5.09e-05	0.00041	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	5.07e-05	0.000408	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.03e-05	0.000405	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.99e-05	0.000402	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.98e-05	0.000401	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.92e-05	0.000396	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.89e-05	0.000394	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.89e-05	0.000394	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.86e-05	0.000392	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.85e-05	0.000391	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.84e-05	0.00039	CbGpPWpGaD
Pipotiazine—Promazine—HTR2A—attention deficit hyperactivity disorder	4.83e-05	0.00503	CrCbGaD
Pipotiazine—HTR2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.79e-05	0.000385	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.61e-05	0.000371	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.59e-05	0.000369	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.53e-05	0.000364	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.5e-05	0.000363	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.47e-05	0.00036	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.47e-05	0.00036	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.42e-05	0.000356	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.4e-05	0.000354	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.4e-05	0.000354	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.38e-05	0.000352	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.36e-05	0.000351	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.35e-05	0.00035	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.29e-05	0.000346	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.29e-05	0.000345	CbGpPWpGaD
Pipotiazine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	4.29e-05	0.000345	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.29e-05	0.000345	CbGpPWpGaD
Pipotiazine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	4.26e-05	0.000343	CbGpPWpGaD
Pipotiazine—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	4.26e-05	0.000343	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.25e-05	0.000342	CbGpPWpGaD
Pipotiazine—Chlorpromazine—HTR2A—attention deficit hyperactivity disorder	4.25e-05	0.00443	CrCbGaD
Pipotiazine—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.23e-05	0.000341	CbGpPWpGaD
Pipotiazine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	4.23e-05	0.00034	CbGpPWpGaD
Pipotiazine—Imipramine—HTR2A—attention deficit hyperactivity disorder	4.23e-05	0.0044	CrCbGaD
Pipotiazine—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	4.21e-05	0.000339	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.21e-05	0.000339	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.18e-05	0.000337	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.16e-05	0.000335	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.09e-05	0.000329	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.96e-05	0.000319	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.95e-05	0.000318	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.94e-05	0.000318	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.89e-05	0.000313	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.89e-05	0.000313	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.86e-05	0.000311	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.84e-05	0.00031	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.84e-05	0.000309	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.83e-05	0.000308	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.8e-05	0.000306	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.78e-05	0.000305	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.77e-05	0.000303	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.77e-05	0.000303	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.76e-05	0.000303	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.72e-05	0.000299	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.7e-05	0.000298	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.7e-05	0.000298	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.69e-05	0.000297	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.66e-05	0.000294	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.63e-05	0.000293	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.59e-05	0.000289	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.58e-05	0.000288	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.53e-05	0.000284	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.48e-05	0.00028	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.46e-05	0.000278	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.42e-05	0.000275	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.42e-05	0.000275	CbGpPWpGaD
Pipotiazine—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.41e-05	0.000275	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.41e-05	0.000274	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.38e-05	0.000272	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.36e-05	0.000271	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	3.35e-05	0.00027	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.35e-05	0.00027	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.32e-05	0.000267	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	3.3e-05	0.000265	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.25e-05	0.000261	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.21e-05	0.000259	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.09e-05	0.000249	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.06e-05	0.000247	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.02e-05	0.000243	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.97e-05	0.000239	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.92e-05	0.000235	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.91e-05	0.000235	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.76e-05	0.000222	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.72e-05	0.000219	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.68e-05	0.000216	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.68e-05	0.000216	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.67e-05	0.000215	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.64e-05	0.000213	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.61e-05	0.00021	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.6e-05	0.000209	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.57e-05	0.000207	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.55e-05	0.000205	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.51e-05	0.000202	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.46e-05	0.000198	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.43e-05	0.000195	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.42e-05	0.000194	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.34e-05	0.000188	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.3e-05	0.000185	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.28e-05	0.000184	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.27e-05	0.000183	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.27e-05	0.000183	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.24e-05	0.000181	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	2.24e-05	0.00018	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.24e-05	0.00018	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	2.21e-05	0.000178	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.2e-05	0.000177	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.12e-05	0.000171	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.12e-05	0.00017	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.09e-05	0.000168	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.05e-05	0.000165	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.05e-05	0.000165	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	2.03e-05	0.000163	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.02e-05	0.000163	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.02e-05	0.000163	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	2.02e-05	0.000162	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	2.01e-05	0.000162	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.01e-05	0.000162	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.99e-05	0.000161	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.99e-05	0.00016	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	1.98e-05	0.000159	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.96e-05	0.000158	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.85e-05	0.000149	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.85e-05	0.000149	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.84e-05	0.000148	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.83e-05	0.000147	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.82e-05	0.000147	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.79e-05	0.000144	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.75e-05	0.000141	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.72e-05	0.000139	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.71e-05	0.000137	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.69e-05	0.000136	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.61e-05	0.00013	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	1.57e-05	0.000126	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.57e-05	0.000126	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	1.54e-05	0.000124	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.53e-05	0.000123	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.48e-05	0.000119	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.48e-05	0.000119	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	1.44e-05	0.000116	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.43e-05	0.000115	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.41e-05	0.000113	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	1.36e-05	0.000109	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	1.35e-05	0.000109	CbGpPWpGaD
Pipotiazine—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.31e-05	0.000105	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.3e-05	0.000105	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.25e-05	0.000101	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	1.22e-05	9.82e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	1.21e-05	9.75e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.21e-05	9.74e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.21e-05	9.74e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.19e-05	9.61e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	1.19e-05	9.59e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.17e-05	9.45e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	1.12e-05	9.03e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.11e-05	8.96e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.11e-05	8.91e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.67e-06	7.79e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	9.5e-06	7.65e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	9.43e-06	7.59e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.21e-06	7.41e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	9.15e-06	7.36e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.13e-06	7.35e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	8.71e-06	7.01e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.85e-06	6.32e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	7.33e-06	5.9e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	7.28e-06	5.86e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.89e-06	5.55e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.78e-06	5.46e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	5.82e-06	4.69e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	5.23e-06	4.21e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	4.81e-06	3.87e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	4.07e-06	3.28e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.14e-06	2.53e-05	CbGpPWpGaD
